ACTIVATION OF THE HUMAN-COMPLEMENT ALTERNATIVE PATHWAY BY LISTERIA-MONOCYTOGENES - EVIDENCE FOR DIRECT BINDING AND PROTEOLYSIS OF THE C3 COMPONENT ON BACTERIA
J. Croize et al., ACTIVATION OF THE HUMAN-COMPLEMENT ALTERNATIVE PATHWAY BY LISTERIA-MONOCYTOGENES - EVIDENCE FOR DIRECT BINDING AND PROTEOLYSIS OF THE C3 COMPONENT ON BACTERIA, Infection and immunity, 61(12), 1993, pp. 5134-5139
The capacity of the intracellular pathogen Listeria monocytogenes to a
ctivate the alternative pathway of human complement was examined. Incu
bation of L. monocytogenes with human serum in optimal conditions (20%
Mg(2+)EGTA [ethylene glycol-bis(beta-aminoethyl ether)-N,N,N',N'-tetr
aacetic acid]-chelated serum) consumed (31.3 +/- 3.9)% of C3 hemolytic
activity and led to similar amounts of C3 deposition among the 27 str
ains tested, except for a rough mutant and the penicillin-induced L fo
rms of strain EGD, which bound reduced amounts of C3. The same results
were obtained with strains belonging to related species (L. innocua,
L. seeligeri, L. welshimeri, and L. ivanovii). Direct evidence is prov
ided that L. monocytogenes induces the deposition of C3b and its cleav
age products iC3b and C3d through ester and amide linkages, as demonst
rated by the analysis of the released products of radiolabelled purifi
ed C3 after treatment with hydroxylamine. Our results clearly demonstr
ate that L. monocytogenes activates the alternative pathway of human c
omplement, suggesting that bacteria in the blood or in tissues of infe
cted patients are opsonized and targeted to C3 receptor-bearing cells
such as macrophages.